Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.
about
PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophagesPeroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factorThe pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.Metabolic Functions of the Lung, Disorders and Associated PathologiesCarbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activationPatient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.Pulmonary macrophage transplantation therapyRegulation of macrophage development and function in peripheral tissuesImpaired lipid metabolism in idiopathic pulmonary alveolar proteinosis.The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects.The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarizationPPARgamma: a novel molecular target in lung disease.The Role of PPARs in Lung Fibrosis.PPARs in alveolar macrophage biology.Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.Role of PPARγ in COX-2 activation in mycobacterial pulmonary inflammation.Whole lung lavage for pulmonary alveolar proteinosis after surgery for spontaneous pneumothorax.Alveolar macrophage cathelicidin deficiency in severe sarcoidosis.Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.Rare lung disease II: pulmonary alveolar proteinosis.Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF.Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function.Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis.GM-CSF pathway correction in pulmonary alveolar proteinosis.Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.Understanding macrophage diversity at the ontogenic and transcriptomic levels.The development and function of lung-resident macrophages and dendritic cells.The Role of PPAR Gamma in Systemic Sclerosis.Cystic Fibrosis Lung Immunity: The Role of the MacrophageToll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages.Targeting cholesterol homeostasis in lung diseases.Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolismAlveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner.Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis.A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP).Mesenchymal Stem Cell Soluble Mediators and Cystic Fibrosis.New mutations in the SLC7A7 gene of two chinese sisters with lysinuric protein intolerance.
P2860
Q23911525-CF8979DC-D7C4-4C88-8E3E-E7FF4E41F61BQ24323199-A25BF07E-99AB-4775-A89E-1F2C1CB262DDQ24814517-5897C94D-01CC-4EDB-8494-7C193F3AB641Q28072037-D7FD7277-AF59-447F-8686-7BE30C19DAACQ28393487-5321B76F-9165-4FC7-98C4-FB004B3B2D6DQ33988125-67F26E44-4657-48BA-9ED5-3D7C6D1C418AQ34539736-72635948-9711-45F3-9528-F44037797338Q34674559-59C41DA5-CE0D-41F4-98CD-E68334B4FC51Q34992980-66A440FF-96E2-43CE-B4A7-620331729F18Q35503543-288990C3-87DC-478D-9527-9E709B65E2A0Q35600280-D03E748C-C884-4B76-8362-EEBA076F604BQ35805954-5E15F8AC-09A3-4ADC-B21A-ABEE2B72D3EFQ35925362-F446F110-922B-4B3E-A431-895DE9927F1DQ36121727-878D57C2-4545-4E12-8F87-397BE60908D2Q36204781-2B7E85E5-77F4-4D1C-BED9-F7B43147587FQ36230193-4B5DA71D-3925-4F15-B571-6E22394338DFQ36299828-54E537DF-1CF1-4583-BEBF-5743CE09A392Q36321921-1FD22129-2CFF-44E8-AC66-CE8C23685801Q37072048-C221E2E8-CCA5-47FE-8367-59A51E6F5F78Q37181748-4C647542-1B68-489A-A7AF-00C7CCD0E135Q37194936-A190331D-0EEC-4A96-938F-16F2B64AD2F4Q37246501-9C10A89D-A941-4309-A6CA-2EFF4F604FF4Q37698322-244B54DD-9F70-46EB-80CC-B88276E81F31Q37778844-9CE3FF38-4CEC-4568-A0B8-919FEF775E3CQ37847083-E7B76140-56DC-4483-A684-8408C2131931Q38260569-103BE084-FA1B-4EA2-AD35-00727E51F6C4Q38293022-06B3C470-2D7D-4DF7-A0BE-5CCA8D32098AQ38524619-38A10177-A4CE-466C-B475-240DA3359E1AQ38874414-A9FF3D79-DFBA-4FFA-8EA5-B519FC3570D4Q39990710-D79EEBF4-5A30-4B30-9E82-93965C8DAB07Q41117124-8BD82460-9CDC-4901-B9DE-3BC03414E3E0Q41581562-669870A2-3753-4511-AD10-30546D4D70EFQ41767102-2161F5F6-F783-4AAF-8FF7-0CBD4CEA7902Q42176757-E2A1A28E-0ACB-43F5-86E5-D715DA72A2EAQ42784201-76F8998D-91E4-4BAE-9283-617CC873B958Q43058950-BA9FA2B6-DD70-4700-BB1C-F402BF48010CQ44598265-F7ED83D0-5358-4ADB-AC5D-E4FF471037ECQ46358328-036C904B-2857-4A29-9EB1-C635D92573E6Q47132756-A392DA3A-607D-47A6-B675-FF3EB5A67D76Q47617629-BC79EE48-A07D-4C76-A1E4-F3D168E359CD
P2860
Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... nts with alveolar proteinosis.
@en
Peroxisome proliferator-activa ...... nts with alveolar proteinosis.
@nl
type
label
Peroxisome proliferator-activa ...... nts with alveolar proteinosis.
@en
Peroxisome proliferator-activa ...... nts with alveolar proteinosis.
@nl
prefLabel
Peroxisome proliferator-activa ...... nts with alveolar proteinosis.
@en
Peroxisome proliferator-activa ...... nts with alveolar proteinosis.
@nl
P2093
P2860
P356
P1476
Peroxisome proliferator-activa ...... nts with alveolar proteinosis.
@en
P2093
Anagha Malur
Baisakhi Raychaudhuri
Barbara P Barna
Carol F Farver
Mani S Kavuru
Mary Jane Thomassen
Susamma Abraham
Tracey L Bonfield
P2860
P304
P356
10.1165/RCMB.2003-0148OC
P577
2003-06-12T00:00:00Z